| Filed On | Filing |
|---|---|
| 06 Aug 2026 |
Form 3: Leary Kevin Daniel, Director
Holds 6,663 shares of Common Stock |
| 29 Dec 2023 |
Form 3: Tayon James Earl, Chief Product Officer
Holds 41,543 shares of Common Stock |
| 04 Oct 2023 |
Form 3: Vulgamott Brent Alan, Chief Operating Officer
Holds 48,733 shares of Common Stock |
| 10 Aug 2022 |
Form 3: Favreau Bradley Thede, Director
Holds 0 shares of No securities are beneficially owned. |
| 08 Jun 2022 |
Form 3: Marconi Luis G, Director
Holds 0 shares of No securities are beneficially owned. |
| 04 May 2021 |
Form 3: Smith Curtis Robert, Chief Marketing Officer
Holds 21,584 shares of Common Stock |
| 27 Aug 2020 |
Form 3: Wadecki Isabell Marie, Director
Holds 0 shares of No securities are beneficially owned. |
| 27 Aug 2020 |
Form 3: Gallagher Mary E, Director
Holds 0 shares of No securities are beneficially owned. |
| 27 Aug 2020 |
Form 3: Gluchowski Gregory J. Jr., Director
Holds 0 shares of No securities are beneficially owned. |
| 27 Aug 2020 |
Form 3: Monheit Barry M, Director
Holds 0 shares of No securities are beneficially owned. |
| 03 Aug 2020 |
Form 3: Smith & Wesson BRANDS, Inc., 10% owner
Holds 1 shares of Common Stock |
| 03 Aug 2020 |
Form 3: Murphy Brian Daniel, Director
Holds 0 shares of No securities are beneficially owned. |
| 03 Aug 2020 |
Form 3: Fulmer Hugh Andrew, See Remarks
Holds 0 shares of No securities are beneficially owned. |
Loading...